$11.6MVenture, 29 March 2026
Funding for NHS deployments, US FDA approval and expansion to other cancer types
- Amount
- $11.6M
- Stage
- Venture
- Announced
- 29 March 2026
- Lead
- IW Capital
- Other investors
- XTX Ventures, Macmillan Cancer Support
- Use of funds
- Funding for NHS deployments, US FDA approval and expansion to other cancer types
- Checked
- Announced by the company
- Sources
- Lucida Medical raises £8.7M for AI prostate cancer diagnosis iwcapital.co.uk
Lucida Medical raises £8.7M for AI prostate cancer diagnosis techround.co.uk